Use of adipose tissue-derived stromal stem cells in treating fistula

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10780132
APP PUB NO 20170189452A1
SERIAL NO

15467984

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are novel methods and compositions utilizing adipose tissue-derived stromal stem cells for treating fistulae.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAKEDA PHARMACEUTICAL COMPANY LIMITED1-1 DOSHOMACHI 4-CHOME CHUO-KU OSAKA-SHI OSAKA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fernández, Miguel María Gema Tres Cantos-Madrid, ES 8 33
García, Arranz Mariano Cantoblanco-Madrid, ES 7 33
García, Castro Rosa Ana Tres Cantos-Madrid, ES 7 33
García, Olmo Damián Cantoblanco-Madrid, ES 7 33
González, De La Peña Manuel Ángel Tres Cantos-Madrid, ES 5 5

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 22, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 22, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00